North American Cardiovascular Devices Market - Investment Analysis and Growth Opportunities

Abstract

Research Overview

Frost & Sullivan's Medical Devices Financial Benchmarking & Analysis (FBA) service presents a broad financial outline of the medical devices industry, highlighting major market and financial trends in key growth segments. It provides a comprehensive financial analysis of leading medical devices firms to support the investment and financial analysis needs of decision makers in the marketplace. The current study within the service focuses on the following key growth sectors of the North American Cardiovascular Devices Market: cardiac rhythm management, interventional cardiology, and cardiac surgery.

Increased Consolidation and Improved Prospects for Venture Capital Investors

The North American Cardiovascular Devices Industry is characterized by a relatively fewer number of participants that are on an aggressive acquisition spree. With the acquisition of Guidant by Boston Scientific, the space is consolidating further. Moreover, smaller companies that develop technologies catering to an unmet need, or that convert a surgery from an in-patient to an out-patient setting, have historically been the takeover targets by larger companies. Against such backdrop, this study aims to address issues such as: the impact of consolidation on venture capital investments in the industry, the effect of the consolidation on the exit market for venture capitalists, the IPO market as an exit strategy for venture capital investors, and the segments that demonstrate significant growth potential and are attracting increased interest.

Rise in Number of Out-Patient Surgeries Providing Additional Investment Opportunities

There is an increasing preference in the market for minimally invasive surgeries amongst patients as well as doctors. These surgeries are associated with lesser trauma, shorter recovery time, and lesser post operative pain. Cardiologists also stand to gain from this trend, as more surgeries can be performed at a given time.Thus, any technology that could convert a surgery from an in-patient to an outpatient setting is considered to be a good investment and is welcomed by the market.